2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitors.
Siu, M., Pastor, R., Liu, W., Barrett, K., Berry, M., Blair, W.S., Chang, C., Chen, J.Z., Eigenbrot, C., Ghilardi, N., Gibbons, P., He, H., Hurley, C.A., Kenny, J.R., Cyrus Khojasteh, S., Le, H., Lee, L., Lyssikatos, J.P., Magnuson, S., Pulk, R., Tsui, V., Ultsch, M., Xiao, Y., Zhu, B.Y., Sampath, D.(2013) Bioorg Med Chem Lett 23: 5014-5021
- PubMed: 23870430 
- DOI: https://doi.org/10.1016/j.bmcl.2013.06.008
- Primary Citation of Related Structures:  
4JI9, 4JIA - PubMed Abstract: 
The advancement of a series of ligand efficient 2-amino-[1,2,4]triazolo[1,5-a]pyridines, initially identified from high-throughput screening, to a JAK2 inhibitor with pharmacodynamic activity in a mouse xenograft model is disclosed.
Organizational Affiliation: 
Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, United States. siu.michael@gene.com